This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. Robust NP-specific humoral and cell-mediated immune responses were observed in all participants given OVX836, whether alone or with Fluarix Tetra.
AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. The anti-Abeta therapy “specifically targets the most toxic forms of Abeta” according to Dr Andrea Pfeifer, CEO of AC Immune SA.
The drug is being evaluated as both a monotherapy and in combination with Merck & Co’s Keytruda (pembrolizumab) for cancers such as melanoma, after demonstrating tumour regression, enhanced T-cell infiltration, and durable immune memory in preclinical studies. This field is required.
The collaboration, under a sponsored research agreement, will focus on mRNA vaccines that can help in modulating the normal immune response of the body for the treatment of certain autoimmune diseases as well as allergic conditions. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. By Cytiva Thematic.
CAR-T therapies are based on the patient’s immune cell modification and can express artificial chimeric receptors that can identify and remove tumour cells. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy.
In this episode, I’ll discuss a possible syndrome that might herald vaccine-induced immune thrombotic thrombocytopenia. Episode 646: Does vaccine-induced immune thrombotic thrombocytopenia have a “pre-VITT syndrome” ? 4 of the patients experienced thrombosis and 7 did not. appeared first on Pharmacy Joe.
Ariceum Therapeutics has entered into an exclusive strategic research collaboration agreement with UCB to discover and develop new systemic targeted radiopharmaceuticals to treat immune-related diseases and solid tumours. Please check your email to download the Whitepaper.
The most common causes of acute liver failure were: viral hepatitis, drug-induced (but not from acetaminophen), auto-immune hepatitis and cause indeterminate. To get access to my free download area with 20 different resources to help hospital pharmacists go to pharmacyjoe.com/free. The relative risk in favor of treatment was 0.56.
Learn all there is to know about the immune cell engager landscape, including clinical achievements, potential response predictors, and novel immune cell-based engager therapeutic discoveries. Download the full event guide to find out more. The post 4th Annual Cell Engager Summit | May 24-26 | Boston, MA appeared first on.
Further, Prof Gromiha said, “Ab-CoV also has a wide range of search and display options through which users can directly search and download the processed data, based on the antibody’s name, viral protein epitope, neutralised viral strain, antibody, and nanobody.
Download the full event guide here for the official agenda. Marc Pelletier , Senior Principal Scientist – Translational Immune Oncology, Novartis. Kate Fitzgerald , Professor & Vice Chair, Department of Medicine, Division of Innate Immunity, University of Massachusetts Chan Medical School.
As our understanding of oncology has increased, it’s become clear that each cancer consists of much more than just the tumour cell – a whole ecosystem of vessels, immune cells, and connective tissues form the tumour micro-environment (TME). They also dig into some of the specific work Faron is doing in this space as an example of these ideas.
The Keytruda immunotherapy increases the body’s immune system ability to help identify and destroy tumour cells. By Cytiva Thematic By downloading this case study, you acknowledge that GlobalData may share your information with Cytiva Thematic and that your personal data will be used as described in their Privacy Policy
However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5
The only MMN therapies currently available are immune globulin, with many pipeline therapies being the same. But argenx claims that this leaves a gap in the market since patients receiving immune globulin often still experience disease progression. Please check your email to download the Report.
Plus 2 add on workshops: • Elucidating the anti-tumor immunity of other immune checkpoint inhibitors in oncology. Ensure your research team secures its place at the forefront of the immune checkpoint inhibitor space by putting this event on the calendar for 2021. . • Utilizing biomarkers to maximize the clinical effect.
Topics include: how cancer vaccines differ from other vaccines, how AI is driving the creation of new therapeutic cancer vaccines, how cancers evade the immune response, and TG4050, the newest drug candidate Transgene presented recently at ASCO. . Tune in to learn more. . You can listen to episode 58 of the? pharmaphorum podcast ?in
Utilize the pre-conference focus day dedicated to Novel Formats and Immune Cell Modulators of multispecifics to further drive your clinical and antibody engineering strategies forward. Download the Full Event Guide here for speakers, presentations, pricing and more. The post 13th World Multispecifics Summit appeared first on.
Yang Liu , Founder, President and Chief Scientific Officer, Oncoimmune will explore the CD24–Siglec-10 pathway as a novel innate immune checkpoint to modulate anti-tumor immunity. To see the full speaker line up, download the full agenda.
According to Aspect’s website, the company’s platform produces tissue therapeutics that are designed to be “biologically functional, immune-protective and suitable for surgical implantation”. Download the full report to understand what to expect and how to align your strategies for success.
Download the full event guide for the speaker faculty and session details. The interface of inflammasome signaling with innate immunity, microbial interactions, metabolism, neuroimmune and other systems.
Challenges arose in ensuring immunity for high-risk populations — such as those with chronic diseases — while public health information was produced too quickly for patients to conduct informed decisions, leading to public distrust. You can view the interactive infographic at the NHC’s website and download the research brief here.
A Phase II study of the pharmacodynamic effects of semorinemab (RG 6100), an investigational drug being developed by Roche and AC Immune, on plasma and cerebrospinal fluid (CSF) also took into account plasma and CSF p-tau levels to determine individuals’ response to treatment. Please check your email to download the Report.
The collaboration will combine 3T Biosciences’ 3T- T-Cell Receptor Antigen and Cross-Reactivity Engine (TRACE) discovery platform with Boehringer Ingelheim’s two-pronged research strategy combining compounds that are directed towards cancer cells and target immune cells. By Cytiva Thematic.
Vitamin A Role of Vitamin A : Vitamin A has many vital functions in your body: It strengthens your immune system. It helps your muscles move and supports your immune system. Vitamin E Role of Vitamin E : Vitamin E supports your immune system and prevents blood clots. It’s essential for your vision.
A Phase II study of the pharmacodynamic effects of semorinemab (RG 6100), an investigational drug being developed by Roche and AC Immune, on plasma and cerebrospinal fluid (CSF) also took into account plasma and CSF p-tau levels to determine individuals’ response to treatment. Please check your email to download the Report.
It is expected to enhance the immune phenotype, quality and consistency of harvested therapeutic cells. A study published in Nature Biomedical Engineering validated the ability of CTRL’s cell processing platform to harvest tumour-reactive immune cells from the blood.
Grøndahl also highlighted SNIPR’s ongoing collaborations with Novo Nordisk and MD Anderson Cancer Center to further explore applications of its technology in cardio-metabolic and immune-oncology treatments, as well as an in-house program focusing on autoimmune diseases. Please check your email to download the Report.
It takes own immune cells of a patient and modifies them to attach and destroy cancer cells. The new CAR-T therapy will be given as a one-off intravenous infusion. Previously, it was available through the Cancer Drugs Fund (CDF).
Download the full event guide here for more information on what you can look forward to. Modulate the immune system to drive efficacy via co-stimulatory targets to drive efficacy in solid tumors with Xencor, Harbour Biomed, Crescendo Biologics, Pieres, and Aptevo.
Vitamin D supports the immune system by enhancing the pathogen-fighting effects of white blood cells, which are important parts of immune defense. Supplementing with vitamin D can especially help to improve mood and cognitive function during the winter months, as well as improve immune function. I recommend doses of 1.5
Quell CEO Iain McGill stated: “This collaboration builds on our pioneering work to develop exquisitely engineered, multi-modular Treg cell therapies for immune disorders and provides excellent validation for the technologies and capabilities we have established. “We
It was engineered with an Fc-silent IgG1 isotype to avoid activation of Fc-receptor-mediated non-specific immune. The bispecific antibody was found to conditionally activate the immune pathway in the tumour microenvironment in vitro and in vivo trials. Please check your email to download the Whitepaper.
PLpro is the second coronavirus protease responsible for suppressing the human immune system, causing more severe Covid-19. Please check your email to download the Whitepaper. The licensed technology specifically includes small molecules found to be efficient PLpro inhibitors.
More than three decades ago, scientists at the National Cancer Institute began exploring ways to fight cancer using the patient’s immune system. It’s used primarily to monitor changes in immune cell phenotype, to monitor therapeutic cells, and to detect and monitor abnormal cells. CAGR between 2020 and 2028.
The most common causes of acute liver failure were: viral hepatitis, drug-induced (but not from acetaminophen), auto-immune hepatitis and cause indeterminate. To get access to my free download area with 20 different resources to help hospital pharmacists go to pharmacyjoe.com/free. The relative risk in favor of treatment was 0.56.
The platform based on Scribe CRISPR by Design applies holistic engineering to convert bacterial immune systems into key genome editing technologies targeting the patients’ specific requirements. “Our goal now is to more broadly enable therapies to help people living with these conditions.”
June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Please check your inbox to download the Whitepaper. Credit: luchschenF /Shutterstock. You will receive an email shortly.
Her body was making numerous inflammatory immune complexes to EVERY protein she was eating! She also began using systemic enzymes (enzymes that are taken away from food and break down inflammatory immune complexes), and started noticing that her eyes and face were less swollen — within a few weeks.
A statement from the company highlighted frexalimab’s mechanism of action of blocking the CD40/CD40L costimulatory pathway, as one that potentially regulates both adaptive and innate immune cell activation and function, which is pivotal in the pathogenesis of MS. Please check your email to download the Report.
In June, the Advisory Committee on Immunization Practices (ACIP) will give guidelines on the appropriate use of the vaccine in the US. Download the full report to understand what to expect and how to align your strategies for success. Please check your email to download the Report.
For more details about the program, speaker faculty or pricing and discounts, download the brochure. In such a fast-paced industry, this is a unique opportunity to provide an overview of the ‘knowns and unknowns’ in the field, and to accelerate the safe development of TIGIT therapies with maximum clinical impact.
The Fc region interacts with the cell surface receptors to cause the protective immune response. The company has previously co-developed drugs that include bispecific T-cell engagers and immune checkpoint modulators. Download the full report to understand what to expect and how to align your strategies for success.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content